Global Patent Index - EP 1071778 A2

EP 1071778 A2 2001-01-31 - SREBP-2-DEFICIENT CELL LINES

Title (en)

SREBP-2-DEFICIENT CELL LINES

Title (de)

SREBP-2-DEFIZIENTE ZELLINIEN

Title (fr)

LIGNEES CELLULAIRES SREBP-2-DEFICIENTES

Publication

EP 1071778 A2 (DE)

Application

EP 99927674 A

Priority

  • DE 9901143 W
  • DE 19816894 A

Abstract (en)

[origin: WO9953052A2] The invention relates to sterol regulatory element binding protein (SREBP)-2-negative eucaryotic cell lines, to the use of said cell lines for sampling and testing substances such as medicaments in the treatment or prevention of, for instance, hypercholesterolaemia, arterioscelerosis or coronary heart disease.

IPC 1-7 (main, further and additional classification)

C12N 15/12; A61K 48/00; C12N 5/10; C12N 15/11

IPC 8 full level (invention and additional information)

A61P 3/06 (2006.01); A61P 9/10 (2006.01); C07K 14/47 (2006.01); C12N 15/12 (2006.01); A61K 48/00 (2006.01)

CPC (invention and additional information)

C07K 14/4702 (2013.01); A61K 48/00 (2013.01)

Citation (search report)

See references of WO 9953052A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9953052 A2 19991021; WO 9953052 A3 20000120; AU 4496999 A 19991101; DE 19816894 C1 20000302; EP 1071778 A2 20010131

INPADOC legal status


2004-05-19 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20031113

2003-06-18 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20030502

2001-01-31 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20001012

2001-01-31 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A2

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE